ContraFect

ContraFect Change in Working Capital

The Change in Working Capital of ContraFect (CFRXQ) as of Oct 18, 2026 is 13.76 M USD. In the previous year, Change in Working Capital was 1.77 M USD — a change of 677.40% (higher).

Change in Working Capital

13.76 MUSD

YoY

677.40%

Last updated:

Change in Working Capital of ContraFect is 2022 13.76 M USD. Change in Working Capital of ContraFect was 2021 1.77 M USD. It decreases by 677.40% higher compared to the previous year.

The ContraFect Change in Working Capital history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Change in Working Capital
Date
Change in Working Capital
Jan 1, 2015
-210,000.00 USD
Jan 1, 2016
790,000.00 USD
Jan 1, 2017
-740,000.00 USD
Jan 1, 2018
2.02 M USD
Jan 1, 2019
-1.71 M USD
Jan 1, 2020
-2.27 M USD
Jan 1, 2021
1.77 M USD
Jan 1, 2022
13.76 M USD
The ContraFect Change in Working Capital history
YEARChange in Working CapitalYoY
13.76 MUSD+677.40%
1.77 MUSD-177.97%
-2.27 MUSD+32.75%
-1.71 MUSD-184.65%
2.02 MUSD-372.97%
-740,000.00USD-193.67%
790,000.00USD-476.19%
-210,000.00USD-84.09%
-1.32 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ContraFect Stock analysis

What does ContraFect do? ContraFect Corp, based in Yonkers, New York, is a clinical-stage biotechnology company focused on developing direct lytic agents (DLAs) such as lysins and amurin peptides to treat life-threatening antibiotic-resistant infections. The company, listed in 2014, employs 23 people and is advancing its lead candidate exebacase (CF-301) for MRSA bloodstream infections and chronic prosthetic joint infections, alongside CF-370 targeting gram-negative bacteria. ContraFect is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ContraFect stock

Change in Working Capital of ContraFect is 13.76 M USD in 2022.

Change in Working Capital of ContraFect changed from 1.77 M USD to 13.76 M USD, representing a 677.40% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Change in Working Capital ContraFect since 2006 – with annual values, charts, and detailed analysis.

Change in working capital reflects the period-over-period change in current assets minus current liabilities. It impacts operating cash flow significantly.

Change in Working Capital's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Change in Working Capital's ContraFect historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — ContraFect

All Key Metrics — ContraFect